Gammagard

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

Gammagard is an immunoglobulin-based drug manufactured by Baxter International.[1] It is a brand of intravenous immunoglobulin.[2]

Early experimental results from a small clinical trial in humans have shown hints that it may protect against the progression of Alzheimer's Disease.[2][3]

In 2013 it failed a phase III clinical trial for Alzheimer's Disease.[4]

References

  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ 2.0 2.1 Lua error in package.lua at line 80: module 'strict' not found.
  3. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  4. ↑ Another Alzheimer's Drug Fails Phase III Trial

External links

<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
Retrieved from "https://infogalactic.com/w/index.php?title=Gammagard&oldid=556188205"